Attached files
| file | filename |
|---|---|
| EX-32 - EXHIBIT 32 - Oxford Immunotec Global PLC | ex32.htm |
| EX-31.2 - EXHIBIT 31.2 - Oxford Immunotec Global PLC | ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Oxford Immunotec Global PLC | ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Oxford Immunotec Global PLC | ex21-1.htm |
| EX-10.20 - EXHIBIT 10.20 - Oxford Immunotec Global PLC | ex10-20.htm |
| 10-K - FORM 10-K - Oxford Immunotec Global PLC | oxfd20161231_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
|
(1) |
Registration Statement (Form S-3 Nos. 333-215236 and 333-200571) of Oxford Immunotec Global PLC, |
|
(2) |
Registration Statement (Form S-8 No. 333-193730) pertaining to the Oxford Immunotec Global PLC 2013 Share Incentive Plan, and |
|
(3) |
Registration Statement (Form S-8 No. 333-192582) pertaining to the Amended and Restated 2008 Stock Incentive Plan of Oxford Immunotec Global PLC; |
of our report dated February 28, 2017 with respect to the consolidated financial statements of Oxford Immunotec Global PLC included in this Annual Report (Form 10-K) of Oxford Immunotec Global PLC for the year ended December 31, 2016.
/s/ Ernst & Young LLP
Reading, United Kingdom
February 28, 2017